Dr. Wataru Akahata

Dr. Wataru Akahata 2016-12-30T17:34:40+00:00

Dr. Wataru Akahata

Ph.D., Co-Founder, Chief Executive Officer and Chief Scientific Officer

Prior to founding VLP Therapeutics, Dr. Akahata was a senior researcher at the Vaccine Research Center, National Institutes of Health (NIH). While working at NIH, he gained over 10 years of experience in vaccine development against emerging infectious disease such as HIV, influenza and alphaviruses. Most notably, Dr. Akahata invented the ckikungunya virus (CHIKV) virus like particle vaccine, which is now under the Phase I trial at NIH. Dr. Akahata was also engaged in the collaboration research with organizations such as the U.S. Army, WHO and other universities involved in the emerging infectious diseases. Dr. Akahata’s research efforts led to a number of patents and CRADA agreement with a major pharmaceutical company and he also received NIH Director’s Award for his work in the development of alphavirus vaccines.

After leaving NIH, Dr. Akahata founded VLP Therapeutics, LLC to focus on developing new generation of vaccines to treat the diseases that lack effective treatments. Dr. Akahata received Ph.D. in Human and Environmental Studies from Graduate School, Kyoto University.